CLARITY News and Research

RSS

The lipid-exchanged, anatomically rigid, imaging/immunostaining compatible, tissue hydrogel (CLARITY) method was initially designed in 2013 by Chung and Deisseroth at the Stanford University School of Medicine. Using this process, post-mortem organs can be labeled for proteins and nucleic acids, enabling analysis of intact samples to create detailed 3D images.

Cytori's first-quarter total revenues increase to $4.4 million

Cytori Therapeutics is reporting its first quarter financial results.

6 May 2010

Momenta Pharmaceuticals first-quarter net loss decreases to $16.1 million

Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex drugs, today reported its financial results for the quarter ended March 31, 2010.

6 May 2010

Gentiva Health Services first-quarter total net revenues up 7.5% to $297.1 million

Gentiva Health Services, Inc., a leading provider of home health and hospice services, today reported first quarter 2010 results.

6 May 2010

Acucela to present data on ACU-4429 oral visual cycle modulator for dry AMD at Retina International meeting

Acucela, a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today that Ryo Kubota, M.D., Ph.D., Acucela's chairman, president and chief executive officer, has been invited to participate in Retina International's annual Scientific & Medical Advisory Board meeting being held in Fort Lauderdale, Florida on May 3, 2010.

3 May 2010

NWO awards 31 grants in Investment Subsidy NWO Medium programme

The Netherlands Organisation for Scientific Research (NWO) has awarded 31 grants in the Investment Subsidy NWO Medium programme for the acquisition of equipment, the setting up of data collections and the production of software and bibliographies. The total investment amounts to 10 million euro.

30 Apr 2010

Human Genome Sciences reports net loss of $47.9M for first-quarter 2010

Human Genome Sciences, Inc. today announced financial results for the quarter ended March 31, 2010, and provided highlights of recent key developments.

29 Apr 2010

After bad publicity, insurer to act early on ending practice of canceling policies of sick patients

WellPoint will put into effect this week a health overhaul provision preventing insurers from canceling policies -- a practice known as rescission -- except in fraud cases, even though the change isn't required until September, the Indianapolis Star reports.

28 Apr 2010

Energizer Holdings reports 6% increase in second-quarter 2010 net sales

Energizer Holdings, Inc., today announced results of its second quarter ended March 31, 2010. Net earnings for the quarter were $88.5 million, or $1.25 per diluted share, versus net earnings of $77.0 million, or $1.30 per diluted share in the second fiscal quarter of 2009.

27 Apr 2010

Amedisys' first-quarter 2010 net service revenues up 20.8%

Amedisys, Inc., one of America's leading home health nursing companies, today reported its financial results for the three-month period ended March 31, 2010. We posted record financial performance with net service revenue and net income attributable to Amedisys, Inc., increasing 20.8% and 35.6%, respectively, over the three-month period ended March 31, 2009.

27 Apr 2010

New data on Cladribine Tablets presented at AAN annual meeting

EMD Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that new data providing further understanding on Cladribine Tablets as a potential new therapeutic option for relapsing forms of multiple sclerosis were presented at the 62nd Annual Meeting of the American Academy of Neurology.

17 Apr 2010

New cardiac CT technology promises low radiation exposure and improved image quality

Cardiovascular disease is the leading cause of death globally and a tremendous burden on the healthcare system. Better detection of hardening or clogging of arteries and other blood vessels before symptoms occur is needed.

15 Apr 2010

Florida to enact health care legislation to improve access to ARV therapy

Florida is poised to enact health care legislation that would add clarity to existing state statutes by requiring that all state-regulated health plans include lifesaving antiretroviral (ARV) HIV/AIDS drugs on their drug formularies or preferred drug lists.

15 Apr 2010

New CZT-based cardiac nuclear imaging system now at Mount Sinai Medical Center

The Mount Sinai Medical Center has become the first in the United States to commercially use a new cardiac nuclear imaging system by GE Healthcare, a cadmium zinc telluride (CZT)-based high-speed, high-resolution camera that drastically reduces imaging time for patients while also reducing radiation exposure compared to previously used technologies.

12 Apr 2010

Clarian Health Partners selects MedVentive as technology partner

Clarian Health Partners, Indiana's largest healthcare system, has selected MedVentive as a technology partner for its clinically-integrated network, Clarian Quality Partners.

9 Apr 2010

Biosense Webster obtains first Ethics Committee approval for CLARITY study

Biosense Webster announces that this week it has obtained its first Ethics Committee approval for the CLARITY study, comparing the 1-year efficacy, safety and efficiency of CARTO(R) 3 System-guided radiofrequency ablation using the NAVISTAR(R) THERMOCOOL(R) Catheter versus fluoroscopy-guided radiofrequency ablation using the Pulmonary Vein Ablation Catheter(R) (PVAC(R), Ablation Frontiers, Medtronic) in patients with paroxysmal atrial fibrillation.

9 Apr 2010

MHS to deploy NextGen EHR and NextGen HIE management solutions

NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare information systems and connectivity solutions, today announced an agreement with Mercy Health System to deploy NextGen® EHR and NextGensm Health Information Exchange.

6 Apr 2010

New technique could allow pilots to peer through fog and doctors to see more precisely into the human body

A new technique for revealing images of hidden objects may one day allow pilots to peer through fog and doctors to see more precisely into the human body without surgery.

3 Apr 2010

Pfizer shares details of financial relationships with U.S. healthcare professionals and researchers

Pfizer Inc. today released detailed information about how and why the company works with a range of healthcare professionals and researchers to advance patient care and develop lifesaving medicines. The information reflects payments or exchanges of value received by licensed U.S. healthcare professionals who consulted with Pfizer about the development and marketing of new medicines and helped to educate other healthcare professionals about the safe and appropriate use of its products.

2 Apr 2010

Americans looking more closely at health-care reform

Health care is on the minds of most Americans today. And according to Euro RSCG Worldwide's Spring 2010 "U.S. Mind and Mood Report," 67.6 percent of men and 61.5 percent of women are more interested in the subject than they were during the previous 12 to 18 months.

1 Apr 2010

Data of focusing on Rebif and Cladribine Tablets to be presented at AAN Annual Meeting

EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, today announced that new data from the company's multiple sclerosis portfolio of approved and investigational treatments will be presented at the 62nd Annual Meeting of the American Academy of Neurology taking place April 10 to 17, in Toronto, Canada.

1 Apr 2010

CLARITY News and Research

Further Reading

Cytori's first-quarter total revenues increase to $4.4 million

Momenta Pharmaceuticals first-quarter net loss decreases to $16.1 million

Gentiva Health Services first-quarter total net revenues up 7.5% to $297.1 million

Acucela to present data on ACU-4429 oral visual cycle modulator for dry AMD at Retina International meeting

NWO awards 31 grants in Investment Subsidy NWO Medium programme

Human Genome Sciences reports net loss of $47.9M for first-quarter 2010

After bad publicity, insurer to act early on ending practice of canceling policies of sick patients

Energizer Holdings reports 6% increase in second-quarter 2010 net sales

Amedisys' first-quarter 2010 net service revenues up 20.8%

New data on Cladribine Tablets presented at AAN annual meeting

New cardiac CT technology promises low radiation exposure and improved image quality

Florida to enact health care legislation to improve access to ARV therapy

New CZT-based cardiac nuclear imaging system now at Mount Sinai Medical Center

Clarian Health Partners selects MedVentive as technology partner

Biosense Webster obtains first Ethics Committee approval for CLARITY study

MHS to deploy NextGen EHR and NextGen HIE management solutions

New technique could allow pilots to peer through fog and doctors to see more precisely into the human body

Pfizer shares details of financial relationships with U.S. healthcare professionals and researchers

Americans looking more closely at health-care reform

Data of focusing on Rebif and Cladribine Tablets to be presented at AAN Annual Meeting

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest Life Science News